Strategies for Delivery of siRNAs to Ovarian Cancer Cells

Strategies for Delivery of siRNAs to Ovarian Cancer Cells

The unmet need for novel therapeutic options for ovarian cancer (OC) deserves further investigation. Among the different novel drugs, small interfering RNAs (siRNAs) are particularly attractive because of their specificity of action and efficacy, as documented in many experimental setups. However, t...

Full description

Bibliographic Details
Main Authors: Rossella Farra, Matea Maruna, Francesca Perrone, Mario Grassi, Fabio Benedetti, Marianna Maddaloni, Maguie El Boustani, Salvo Parisi, Flavio Rizzolio, Giancarlo Forte, Fabrizio Zanconati, Maja Cemazar, Urska Kamensek, Barbara Dapas, Gabriele Grassi
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Pharmaceutics
Subjects:
ovarian cancer
sirna
polymer
lipid
delivery
Online Access:https://www.mdpi.com/1999-4923/11/10/547

Internet

https://www.mdpi.com/1999-4923/11/10/547

Similar Items